Brazil Anvisa 2026 Health Collaboration Mission in China
In 2026, Anvisa joined Brazil’s government mission to China to strengthen cooperation on health products, including medicines, medical devices, and blood products. The mission focuses on regulatory alignment, technology transfer, and sharing of technical knowledge. Director Daniela Marreco officially represents Anvisa, engaging with Chinese authorities, companies, and smart hospitals. This collaboration aims to streamline product registration while maintaining safety and quality, enabling faster access to advanced medical technologies in Brazil.
In March 2026, Anvisa joined the Brazilian government delegation visiting China to strengthen bilateral cooperation on health products. Led by Director Daniela Marreco, the mission focuses on regulatory alignment, technology transfer to Brazil, and high-quality production of medicines, medical devices, and blood products. The initiative aims to make the registration process more efficient, ensuring safe, high-quality medical technologies reach the Brazilian market faster.
Key Objectives of the Mission
Strengthen bilateral cooperation between Brazil and China in health regulation
Focus on technology transfer to Brazil for medicines, medical devices, and blood products
Align regulatory standards for faster, safe market access
Promote sharing of technical and scientific information
Visits and Engagements
Tours of pharmaceutical and biotech companies producing medicines and vaccines
Visits to smart hospitals and health institutions to explore advanced technologies
Meetings with Chinese health authorities to discuss collaboration and regulatory alignment
Official Representation
Daniela Marreco, Anvisa Director, represents the agency in the Brazilian government delegation
Supports discussions on regulatory harmonization, compliance, and technology transfer
Ensures Brazilian interests are aligned with high-quality manufacturing and public health standards
Benefits for Brazilian Public Health
Streamlined registration and approval of medical products
Transparent, efficient regulatory pathways
Access to new technologies and treatments
Assurance of safety and high manufacturing standards for Brazilian patients
Next Steps for Collaboration
Continued technical exchanges and bilateral meetings
Harmonization of documentation and regulatory processes
Monitoring implementation of agreements and technology transfer initiatives
Internal Links
Learn more about ANVISA Brazil Medical Device Registration
Learn more about AI-Supported ANVISA Notification
External Links
Market · Jul 24, 2026ANVISA Brazil Medical Device RegistrationCase Study · Jul 22, 2026Single-Use Endoscope Registration in Brazil: Time & CostResearch Report · Jul 27, 2026IVD Global Market Access 2026Research Report · Jul 20, 2026Orthopedic Implants: The 2026 Global Market-Access MapResearch Report · Jul 13, 2026Aesthetic Devices: The 2026 Global Market-Access MapBlog Article · Jul 9, 2026How to register medical devices and IVDs in BrazilVideo · Aug 1, 2025Brazil’s UDI: Key Insights for Medical Device ManufacturersVideo · Jul 21, 2025How to Register a Medical Device in BrazilMarket Service · Jul 24, 2026ANVISA Brazil Medical Device & IVD Classification & GroupingMarket Service · Jul 24, 2026ANVISA Brazil Medical Device Labeling RequirementsLet's Talk,
Anywhere You Are.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us